Puchalski R B, Fahl W E
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2443-7. doi: 10.1073/pnas.87.7.2443.
Increased levels of glutathione S-transferase (GST; RX:glutathione R-transferase; EC 2.5.1.18) mRNA, protein, and activity in tumor biopsy samples and in drug-resistant cultured cells are associated with resistance to anticancer drugs. We report that each of three full-length cloned GST cDNAs, that for pi (acidic), Ya (basic), and Yb1 (neutral), can confer drug resistance when expressed in cultured mammalian cells. In one approach, stably transfected mouse C3H/10T1/2 cells that express GST pi, Ya, or Yb1 were cloned and analyzed for drug resistance in colony-forming assays. Transiently transfected COS cells that were sorted on a fluorescence-activated cell sorter were used in the second approach to avoid interclonal variation in factors other than the recombinant GST and to show that reversion of transient GST expression correlated with loss of drug resistance. A sorting technique, developed to separate the 20% of the electroporated COS cell population that transiently expressed GST pi, Ya, or Yb1 from the nonexpressing population, was based on a GST-catalyzed intracellular conjugation of glutathione to the fluorescent labeling reagent monochlorobimane. GST Ya conferred the greatest increase in resistance to chlorambucil and melphalan (1.3- to 2.9-fold), Yb1 conferred the greatest increase in resistance to cisplatin (1.5-fold), and pi conferred the greatest increase in resistance to a racemic mixture of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a] pyrene and 7 alpha,8 beta-dihydroxy-9 beta,10 beta-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene and doxorubicin (1.5- and 1.3-fold) relative to controls. These resistance values to alkylating agents are commensurate with values observed clinically. Cytotoxicity curves representing recombinant GST+ populations were significantly different from their controls with P values ranging from 0.005 to 0.0001. No resistance to vinblastine was detected. Conferred drug resistance was proportional to the magnitude of GST Ya expression, and reversion of transient expression in GST Ya+ COS cell clones to a GST Ya- phenotype was associated with total loss of drug resistance.
肿瘤活检样本和耐药培养细胞中谷胱甘肽S-转移酶(GST;RX:谷胱甘肽R-转移酶;EC 2.5.1.18)的mRNA、蛋白质和活性水平升高与抗癌药物耐药性相关。我们报告,三个全长克隆的GST cDNA,即pi(酸性)、Ya(碱性)和Yb1(中性),在培养的哺乳动物细胞中表达时均可赋予耐药性。在一种方法中,对稳定转染表达GST pi、Ya或Yb1的小鼠C3H/10T1/2细胞进行克隆,并在集落形成试验中分析其耐药性。在第二种方法中,使用在荧光激活细胞分选仪上分选的瞬时转染COS细胞,以避免除重组GST之外的因素的克隆间变异,并表明瞬时GST表达的逆转与耐药性丧失相关。一种分选技术基于GST催化谷胱甘肽与荧光标记试剂单氯联苯胺的细胞内缀合,用于从非表达群体中分离出瞬时表达GST pi、Ya或Yb1的20%电穿孔COS细胞群体。与对照相比,GST Ya对苯丁酸氮芥和美法仑的耐药性增加最大(1.3至2.9倍),Yb1对顺铂的耐药性增加最大(1.5倍),pi对7β,8α-二羟基-9α,10α-环氧-7,8,9,10-四氢苯并[a]芘和7α,8β-二羟基-9β,10β-环氧-7,8,9,10-四氢苯并[a]芘外消旋混合物和阿霉素的耐药性增加最大(1.5倍和1.3倍)。这些对烷化剂的耐药值与临床观察到的值相当。代表重组GST+群体的细胞毒性曲线与对照有显著差异,P值范围为0.005至0.0001。未检测到对长春碱的耐药性。赋予的耐药性与GST Ya表达量成正比,GST Ya+ COS细胞克隆中瞬时表达向GST Ya-表型的逆转与耐药性完全丧失相关。